Subareolar XXXX of the breast.

@entity1 @entity3821 @entity1373 @entity4261 @entity189 @entity1897 @entity30559 @entity652
Sclerosing @entity1373 occurs in various locations in the breast. In the nipple, the process produces a distinct clinicopathological entity referred to as @entity652 or @entity30559 ( @entity30559 ). @entity1897 have been termed radial scar and nonencapsulated sclerosing lesions. This report describes 12 @entity1 who presented with sclerosing @entity1373 in the subareolar portion of the breast. The term @entity1373 ( @entity1373 ) is proposed for this condition. The average age of the @entity1 was 46 years (26-73 years). None of the lesions, which averaged 1.2 cm (0.6 to 2.0 cm), involved the nipple. All were beneath the nipple and/or areola or in the breast close to the areola. Three @entity1 had bloody nipple discharge but none had nipple erosion or other signs suggestive of @entity4261 . Five @entity1 were well 9 months to 3 years, 9 months (average, 2 years, 7 months) after excisional biopsy. Two other @entity1 had persistent @entity1373 reexcised 2 years, 6 months and 2 years, 10 months, respectively, after diagnosis. Both were well 1 year later. There is no follow up in two @entity1 treated by excision. Three @entity1 are well after treatment by mastectomy. In one of those @entity1 , @entity3821 was found arising in @entity1373 . The clinical presentation of @entity1373 differs sufficiently from other proliferative duct lesions to warrant considering it a distinct disease process. It does not appear to be associated with a particular proclivity to evolve into @entity189 and short-term follow-up suggests that excisional biopsy is probably adequate therapy.
